DNA adenine methylase

Japanese Healthcare Startup Ubie, Inc. Closes Extended Series C Round at $45 million, Establishes Subsidiary in NY

Retrieved on: 
Thursday, December 8, 2022

TOKYO, Dec. 8, 2022 /PRNewswire/ --Ubie, Inc., a Tokyo-based healthcare startup, announced on December 8 that it has closed its Series C round at $45 million by raising $19 million in an extension round.

Key Points: 
  • TOKYO, Dec. 8, 2022 /PRNewswire/ --Ubie, Inc., a Tokyo-based healthcare startup, announced on December 8 that it has closed its Series C round at $45 million by raising $19 million in an extension round.
  • The extension round money was raised from SOGO MEDICAL CO., LTD., AAIC Investment Pte.
  • Ltd., Japan Impact Investment II Limited Partnership, and Rakuten Capital, while loans extended from the Shoko Chukin Bank, Ltd., Japan Finance Corporation, and Mizuho Bank, Ltd.
  • Leveraging the Series C funding, Ubie established a local subsidiary in New York on October 4, 2022.

Japan Deep Learning Market Research Report 2022: Image Recognition, Signal Recognition, Data Mining - Competition Forecast and Opportunities to 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 18, 2022

The "Japan Deep Learning Market, By Offering (Hardware, Software, and Services), By Application (Image Recognition, Signal Recognition, and Data Mining), By End-User Industry, By Architecture, and By Region, Competition Forecast and Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Japan Deep Learning Market, By Offering (Hardware, Software, and Services), By Application (Image Recognition, Signal Recognition, and Data Mining), By End-User Industry, By Architecture, and By Region, Competition Forecast and Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
  • The Japan deep learning market is projected to grow at a significant CAGR during the forecast period, 2023-2027.
  • To estimate and forecast the market size of Japan deep learning market from 2023 to 2027 and growth rate until 2027.
  • To identify key sustainable strategies adopted by market players in Japan deep learning market.

Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total

Retrieved on: 
Monday, August 22, 2022

TOKYO and SINGAPORE, Aug. 22, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," announced that it has raised $26.2 million (*1) in the 1st round of Series C funding. New investors in the round include Norinchukin Capital Co., Ltd., NVenture Capital Limited (wholly owned subsidiary of NEC Capital Solutions Limited), The Dai-ichi Life Insurance Company, Limited, and Egg FORWARD, Inc., while existing investors include SUZUKEN CO., LTD. To date, Ubie has raised $59.8 million (*2).

Key Points: 
  • Ubie is one of the few startups in the world with a medical data platform thathas direct contact with both patients and medical institutions.
  • Ubie offers twoservices that focus on the "medical questionnaire" as a gateway to healthcare,using AI as its core technology.
  • The service has been introduced to more than 1,000 medical institutions worldwide and continues to improve the operationalefficiency of these institutions.
  • Ubie is promoting the creation of a society in which anyone can accessmedical care that suits them best.

Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.

Retrieved on: 
Tuesday, April 26, 2022

TOKYO and SINGAPORE, April 26, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," has launched in the United States an "AI-powered symptom checker" ( https://ubiehealth.com ) that allows users to enter symptoms and discover related diseases.

Key Points: 
  • (*) Ubie's first product offering, the "AI-powered patient intake," is a service that streamlines the medical interview process for medical institutions.
  • This service is based on a database of approximately50,000 medical papers from around the world, compiled by more than 50 activephysicians.
  • Ubie's second offering "AI-powered symptom checker" uses the same database as the AI-powered patient intake service and evolves daily to reflect clinical diagnosis data from physicians worldwide.
  • Ubie is a Japanese healthtech startup founded by a medical doctor and an engineer in 2017.